Advanced search×

The influence of technological parameters on the physicochemical properties of blank PLGA nanoparticles.

Pharmazie 65(9):665-9 (2010) PMID 21038843

In this work, PLGA nanoparticles were prepared by an emulsification-diffusion technique. The main objective was to optimize the preparation of formulations by evaluating the influence of the technological parameters on the physicochemical properties of PLGA nanoparticles. The effects of variations in polymer and emulsifier concentrations, and homogenization duration, rate and type on the particle size distribution, surface charge and morphology of nanoparticles were assessed. The smallest nanoparticles (177.53 +/- 2.78 nm) were obtained with a 2% PLGA (w/v) concentration in the organic phase and 3% PVA (w/v) in the aqueous phase and were prepared by an emulsification-diffusion method via ultrasonic homogenization at a power of 80 W applied for 30 s. It was observed that nanoparticles prepared by Ultra Turrax were more spherical but larger. In addition, increasing the PVA concentration in the aqueous phase, increasing the PLGA concentration in the organic phase and increasing the homogenization rate decreased the zeta potential values of PLGA nanoparticles.

Version: za2963e q8za7 q8zb4 q8zc4 q8zde q8zec q8zfe q8zg7

Similar articles you may find interesting…

  1. Trastuzumab-functionalized nanoparticles of biodegradable copolymers for targeted delivery of docetaxel.

    Nanomedicine (Lond) 4(4):431-45 (2009) PMID 19505246

  2. Preparation and characterization of tramadol PEG-coated multivesicular liposomes for sustained release.

    Pharmazie 65(7):467-70 (2010) PMID 20662312

    The purpose of the present study was to prepare multivesicular liposomes (MVL) with a high drug loading capacity for intramuscular sustained release and to investigate their potential applicability towards tramadol, and to improve the stability of liposomes by coating PEG. The basic physiochemical p...
  3. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles.

    Drug Dev Ind Pharm 35(3):305-10 (2009) PMID 18798089

    We extracted it from Crataegus pinnatifida for the first time. To achieve a high bioavailability, targeting effect, stability, and an intravenous (i.v.) administration, the UA phospholipid nanopowders (UA-PL-NP) were prepared, characterized, and evaluated. With soybean phospholipid as the carrier an...